The rand was firmer on Wednesday, in line with its emerging-market peers, as progress in the development of a Covid-19 vaccine boosted investor risk appetite.

The US pharmaceutical company Moderna reported progress in the development of a Covid-19 vaccine, saying that the vaccine produced antibiotics to the coronavirus in all patients tested in an initial safety trial. The findings raised hopes that a vaccine could be brought to market quickly...

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as exclusive Financial Times articles, ProfileData financial data, and digital access to the Sunday Times and Sunday Times Daily.

Already subscribed? Simply sign in below.

Questions or problems? Email or call 0860 52 52 00. Got a subscription voucher? Redeem it now